Effect of enhanced external counterpulsation on coronary slow flow and its relation with endothelial function and inflammation: A mid-term follow-up study

Cardiology (Switzerland)

Volumn 122, Issue 4, 2012, Pages 260-268

  Luo, Chufan ^a,b   Liu, Donghong ^a   Wu, Guifu ^a,b   Hu, Chengheng ^a   Zhang, Yan ^b   Du, Zhimin ^a,b   Dong, Yugang ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

Author keywords

Coronary flow reserve; Coronary slow flow; Enhanced external counterpulsation; Flow mediated dilatation; High sensitivity C reactive protein; Transthoracic Doppler echocardiography

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ANGINA PECTORIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY FLOW RESERVE; CORONARY SLOW FLOW; COUNTERPULSATION; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOGRAPHY; ENDOTHELIUM; ENHANCED EXTERNAL COUNTERPULSATION; FEMALE; FOLLOW UP; HUMAN; MALE; PRIORITY JOURNAL;

BLOOD FLOW VELOCITY; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CORONARY CIRCULATION; CORONARY DISEASE; COUNTERPULSATION; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VASODILATION;

EID: 84865058054     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000339876     Document Type: Article

References (32)

1. Paul LC, Jani D, Menete A, Mocumbi AO, Ferreira B: Coronary slow-flow phenomenon. Cardiovasc J Afr 2007; 18: 385-386. (Pubitemid 351300625)
2. Tambe AA, Demany MA, Zimmerman HA, Mascarenhas E: Angina pectoris and slow flow velocity of dye in coronary arteries-A new angiographic finding. Am Heart J 1972; 84:66-71.
3. Albayrak S, Ordu S, Yuksel H, Ozhan H, Yazgan O, Yazici M: Efficacy of nebivolol on flow-mediated dilation in patients with slow coronary flow. Int Heart J 2009; 50:545-553.
4. Tiryakioglu S, Tiryakioglu O, Ari H, Basel MC, Bozat T: Effects of nebivolol on endo-thelial function and exercise parameters in patients with slow coronary flow. Clin Med Cardiol 2009; 3:115-119.
5. Fragasso G: Nebivolol in patients with coronary slow flow: the right drug for the right case. Anadolu Kardiyol Derg 2009; 9: 296-297.
6. Braith RW, Conti CR, Nichols WW, et al: Enhanced external counterpulsation improves peripheral artery flow-mediated dilation in patients with chronic angina: a randomized sham-controlled study. Circulation 2010; 122:1612-1620.
7. Zhang Y, He X, Chen X, et al: Enhanced external counterpulsation inhibits intimal hy-perplasia by modifying shear stress responsive gene expression in hypercholesterolemic pigs. Circulation 2007; 116: 526-534. (Pubitemid 47450261)
8. Bonetti PO, Barsness GW, Keelan PC, et al: Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. J Am Coll Cardiol 2003; 41:1761-1768. (Pubitemid 36584250)
9. McKenna C, McDaid C, Suekarran S, et al: Enhanced external counterpulsation for the treatment of stable angina and heart failure: a systematic review and economic analysis. Health Technol Assess 2009; 13:iii-iv, ix-xi, 1-90.
10. Celik T, Iyisoy A, Yuksel UC, Amasyali B: A new treatment modality in management of patients w it h ca rd iac sy ndrome X: enhanced external counterpulsation. Int J Cardiol 2010; 143:94-95.
11. Kronhaus KD, Lawson WE: Enhanced external counterpulsation is an effective treatment for syndrome X. Int J Cardiol 2009; 135: 256-257.
12. Luo C, Liu D, Du Z, et al: Short-term effects of enhanced external counterpulsation on transthoracic coronary flow velocity and reserve in patients with coronary slow flow. Int J Cardiol 2012; 154: 84-85.
13. Gibson CM, Cannon CP, Daley WL, et al: TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996; 93: 879-888. (Pubitemid 26074824)
14. Luo C, Wu X, Huang Z, et al: Documentation of impaired coronary blood flow by TIMI frame count method in patients with atrial fibrillation. Int J Cardiol 2012, E-pub ahead of print.
15. Zhang Y, He X, Liu D, et al: Enhanced external counterpulsation attenuates atherosclerosis progression through modulation of proinflammatory signal pathway. Arterio-scler Thromb Vasc Biol 2010; 30:773-780.
16. Wu G, Du Z, Hu C, et al: Angiogenic effects of long-term enhanced external counterpul-sation in a dog model of myocardial infarction. Am J Physiol Heart Circ Physiol 2006; 290:H248-H254.
17. Liu Y, Xiong Y, Liu D, Luo C, Zhang Y, Wu G, Xie Q, Dong Y, Zheng Z: The effect of enhanced external counterpulsation on C-re-active protein and flow-mediated dilation in porcine model of hypercholesterolaemia. Clin Physiol Funct Imaging 2012; 32: 262-267.
18. Lee S, Otsuji Y, Minagoe S, et al: Correlation between distal left anterior descending artery flow velocity by transthoracic Dopp-ler echocardiography and corrected TIMI frame count before mechanical reperfusion in patients with anterior acute myocardial infarction. Circ J 2005; 69:1022-1028. (Pubitemid 41603085)
19. Caliskan M, Erdogan D, Gullu H, et al: Effects of atorvastatin on coronary flow reserve in patients with slow coronary flow. Clin Cardiol 2007; 30: 475-479. (Pubitemid 47438717)
20. Hozumi T, Yoshida K, Akasaka T, et al: Non-invasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography: comparison with invasive technique. J Am Coll Cardiol 1998; 32:1251-1259. (Pubitemid 28522380)
21. Mangieri E, Macchiarelli G, Ciavolella M, et al: Slow coronary flow: clinical and histo-pathological features in patients with otherwise normal epicardial coronary arteries. Cathet Cardiovasc Diagn 1996; 37: 375-381. (Pubitemid 26100780)
22. Mosseri M, Yarom R, Gotsman MS, Hasin Y: Histologic evidence for small-vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation 1986; 74: 964-972. (Pubitemid 17174942)
23. Sezgin N, Barutcu I, Sezgin AT, et al: Plasma nitric oxide level and its role in slow coronary f low phenomenon. Int Heart J 2005; 46: 373-382.
24. Sezgin AT, Sigirci A, Barutcu I, et al: Vascular endothelial function in patients with slow coronary flow. Coron Artery Dis 2003; 14: 155-161. (Pubitemid 36543418)
25. Turhan H, Saydam GS, Erbay AR, et al: Increased plasma soluble adhesion molecules; ICAM-1, VCAM-1, and E-selectin levels in patients with slow coronary flow. Int J Car-diol 2006; 108:224-230. (Pubitemid 43330618)
26. Nurkalem Z, Orhan AL, Alper AT, et al: The relation between insulin resistance determined by homeostatic (corrected from haemostatic) modelling and slow coronary flow. Ann Acad Med Singapore 2008; 37: 188-191. (Pubitemid 351547779)
27. Saya S, Hennebry TA, Lozano P, Lazzara R, Schechter E: Coronary slow flow phenomenon and risk for sudden cardiac death due to ventricular arrhythmias: a case report and review of literature. Clin Cardiol 2008; 31: 352-355.
28. Kurtoglu N, Akcay A, Dindar I: Usefulness of oral dipyridamole therapy for angio-graphic slow coronary artery flow. Am J Cardiol 2001; 87:777-779, A8. (Pubitemid 32209098)
29. Masuda D, Nohara R, Hirai T, et al: Enhanced external counterpulsation improved myocardial perfusion and coronary flow reserve in patients with chronic stable angina: evaluation by (13)N-ammonia positron emission tomography. Eur Heart J 2001; 22: 1451-1458. (Pubitemid 32769172)
30. Michaels AD, Accad M, Ports TA, Grossman W: Left ventricular systolic unloading and augmentation of intracoronary pressure and Doppler flow during enhanced external counterpulsation. Circulation 2002; 106: 1237-1242. (Pubitemid 34988642)
31. Casey DP, Conti CR, Nichols WW, Choi CY, Khuddus MA, Braith RW: Effect of enhanced external counterpulsation on inflammatory cytokines and adhesion molecules in patients with angina pectoris and angiographic coronary artery disease. Am J Cardiol 2008; 101: 300-302. (Pubitemid 351162955)
32. Kitsou V, Xanthos T, Roberts R, Karlis GM, Padadimitriou L: Enhanced external coun-terpulsation: mechanisms of action and clinical applications. Acta Cardiol 2010; 65: 239-247.